GlassScriptPhysician profile
Steven J Warta
NPI 1972688117
$1,151.73
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,152.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $213.57 | 2021 | |
| Amgen INC. | $185.99 | 2021 | |
| Genentech USA, INC. | $158.88 | 2021 | |
| Sun Pharmaceutical Industries INC. | $99.61 | 2021 | |
| Abbvie INC. | $89.12 | 2021 | |
| Paratek Pharmaceuticals, INC. | $79.21 | 2021 | |
| Janssen Biotech, INC. | $79.09 | 2021 | |
| Lilly USA, LLC | $47.33 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $36.41 | 2021 | |
| Pfizer INC. | $31.73 | 2021 | |
| Ucb, INC. | $25.42 | 2021 | |
| Almirall LLC | $24.05 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $21.79 | 2021 | |
| Genzyme Corporation | $21.60 | 2021 | |
| Vyne Pharmaceuticals INC. | $20.85 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $17.08 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Warta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.